In an article for Pharmaceutical Processing World, Emerson’s Kristel Biehler writes that strategic automation systems can enable seamless technology transfer and scalability where cell and gene therapy manufacturers face unique challenges in ramping up production while maintaining quality and compliance.
Latest News
Emerson Announces OPTIMIZE 26 Conference for AspenTech Users
Premier event debuts Innovation Zone and highlights how emerging technologies are driving operational performance
Emerson Selected by Spain’s National Gas Grid Operator to Support Stable and Safe Energy Supply...
Enagás deploys AspenTech Digital Grid Management solutions to advance energy reliability and decarbonization efforts
